RFLRFLReal Estate · Real Estate Services

RFL Stock Forecast: Rafael Holdings, Inc. Price Predictions for 2026-2027

Last close, 17 Nov 2026
$0.91
−5.84% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 54 of 100 as at 16 Nov 2026 — in the upper half.

Market cap
$55.8M
Ticker Nerd rank
54/ 100
Median analyst target
—
Analysts covering
—
Revenue$179K+132.5% y/y
Operating income−$6.9M
Net income−$2.9M
Free cash flow−$7.3M
Quarterly, 8 quarters to 30 Apr 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−14.6%
1M
−34.3%
YTD
−22.6%
1Y
−25.1%
From 52W high
−75.8%
From 52W low
0.0%
$0.91
$3.78
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

RFL stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Rafael Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 16 Nov 2026
54/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
79
Volatility
73
Growth
65
Quality
59
Accruals
58
Momentum
54
Issuance
46
Value
45
Revisions
25

Size (79): Smaller than most of the companies we track.

Revisions (25): Analysts have, on balance, been cutting their forecasts.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

RFL stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on RFL, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$1.50$2.00$2.50$3.00Jan 26Apr 26Jul 26Oct 26RFL

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

RFL appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

RFL vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 17 Nov 2026, Rafael Holdings, Inc. returned −25.1% against +11.2% for the S&P 500, dividends included.

RFL vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200250Jan 26Apr 26Jul 26Oct 26RFLS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

RFL analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Rafael Holdings, Inc. (RFL) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
14.3×

Cheaper than 46% of US stocks

Price / sales
62.7×

Cheaper than 4% of US stocks

Price / book
0.8×

Cheaper than 74% of US stocks

EV / EBITDA
−1.2×

Cheaper than 72% of US stocks

Growth & margins
Revenue growth (YoY)
−30.3%

Higher than 9% of US stocks

Earnings growth (YoY)
132.5%

Higher than 87% of US stocks

Gross margin
95.5%

Higher than 98% of US stocks

Operating margin
−3822.5%

Higher than 3% of US stocks

Net margin
0.0%

Higher than 29% of US stocks

Returns & dividend
Return on equity
−32.8%

Higher than 26% of US stocks

Return on assets
−21.2%

Higher than 19% of US stocks

Dividend yield
4704.1%

Higher than 99% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Rafael Holdings, Inc. (RFL) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Rafael Holdings, Inc. has a market value of $55.8M and an enterprise value of $40.0M.

  • Revenue in the twelve months to 30 Apr 2026: $992K. The latest quarter shrank 30.3% year on year.

  • Net income over the same four quarters: −$23.1M, a −2325.9% net margin.

  • Diluted earnings per share, trailing twelve months: −$0.59.

  • Free cash flow in the twelve months to 30 Apr 2026: −$24.8M, after $72K of capital spending.

  • Shares outstanding: 52.0M.

  • Trailing P/E: 14.3×.

  • Forward dividend yield: 4704.05%, paying out 0% of earnings.

  • Rafael Holdings, Inc. employs 15 people — $66K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 Apr 2026 · market figures as at 17 Nov 2026

Data provided by Twelve Data

Peers

RFL vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelReal Estate Services
CompanyMarket capTKN rank
RFLRafael Holdings, Inc.$55.8M54
EUDAEUDA Health Holdings Ltd.$45.9M9
ASPSAltisource Portfolio Solutions SA$65.2M40
MAYSJ.W. Mays, Inc.$83.5M35
SRGSeritage Growth Properties$87.3M63
STHOStar Holdings$93.8M88
DUOFangdd Network Group Ltd.$20.2M28

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Rafael Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest RFL news & analysis

Rafael Holdings to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

GlobeNewsWire · 3 Nov 2026neutral

Rafael Holdings announced it will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 9, 2026, and hold one-on-one meetings with institutional investors.

Why it matters — The announcement provides RFL watchers with details about the company’s upcoming conference participation and investor meetings.

Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C

GlobeNewsWire · 29 Oct 2026positive

Rafael Holdings announced that an NDA for Trappsol® Cyclo™ (remibetadex), for treating Niemann-Pick disease type C, was submitted to the FDA. The application is supported by the Phase 3 TransportNPC study, earlier clinical studies, and an overall survival analysis against external registry controls.

Why it matters — The FDA submission is a development milestone for a drug associated with Rafael Holdings.

FAQ

Frequently asked questions about RFL stock

How does Ticker Nerd's model rank RFL?

As at 16 Nov 2026, Rafael Holdings, Inc. ranks 54 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (79 of 100).

What is the RFL stock forecast for 2030?

No analyst covering Rafael Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RFL are extrapolating price history, which says nothing about the business.

How has RFL stock performed over the past year?

Rafael Holdings, Inc. returned -25.1% over the 12 months to 17 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Rafael Holdings, Inc. do?

Rafael Holdings Inc. Class B Common Stock is an equity security representing ownership in Rafael Holdings, a company focused on healthcare-related investments and operations.

What is the latest news on RFL?

The most recent item we track (GlobeNewsWire, 3 Nov 2026): "Rafael Holdings to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference". Rafael Holdings announced it will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 9, 2026, and hold one-on-one meetings with institutional investors.

Company

About Rafael Holdings, Inc.

Rafael Holdings Inc. Class B Common Stock is an equity security representing ownership in Rafael Holdings, a company focused on healthcare-related investments and operations. The company is primarily involved in clinical and early-stage pharmaceutical interests, including oncology-oriented drug development, as well as medical devices and infusion technology activities. Its current business is organized across Healthcare, Infusion Technology, and Real Estate segments, giving it exposure to both life sciences and commercial property assets. Rafael Holdings also holds interests in companies working on therapies that target metabolic differences between normal and cancer cells, which places it within the specialized biopharmaceutical landscape. Headquartered in Newark, New Jersey, Rafael Holdings serves as a publicly traded vehicle for investors seeking exposure to a diversified mix of healthcare innovation and real estate holdings.

CEO Mr. Howard S. Jonas · 15 employees · United States · https://www.rafaelholdings.com